[
  {
    "ts": null,
    "headline": "Cencora: Yet Another Strong Quarter, But Valuations Still Aren't Cheap",
    "summary": "Cencora: Yet Another Strong Quarter, But Valuations Still Aren't Cheap",
    "url": "https://finnhub.io/api/news?id=5f5293c5f7256d2ea6433bae53d2dc626b6c5b3a8345edbf5a71bf34bb438e88",
    "source": "SeekingAlpha",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1755009098,
      "headline": "Cencora: Yet Another Strong Quarter, But Valuations Still Aren't Cheap",
      "id": 136321096,
      "image": "",
      "related": "COR",
      "source": "SeekingAlpha",
      "summary": "",
      "url": "https://finnhub.io/api/news?id=5f5293c5f7256d2ea6433bae53d2dc626b6c5b3a8345edbf5a71bf34bb438e88"
    }
  },
  {
    "ts": null,
    "headline": "COR Q2 Deep Dive: Specialty Growth, International Headwinds, and Guidance Update",
    "summary": "Healthcare distributor Cencora (NYSE:COR) announced better-than-expected revenue in Q2 CY2025, with sales up 8.7% year on year to $80.66 billion. Its non-GAAP profit of $4 per share was 4.2% above analysts’ consensus estimates.",
    "url": "https://finnhub.io/api/news?id=17008722545f6a64de61fe86e7cdb4fae4f07a77f2b6559214de948579c4a699",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1754983005,
      "headline": "COR Q2 Deep Dive: Specialty Growth, International Headwinds, and Guidance Update",
      "id": 136316350,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "COR",
      "source": "Yahoo",
      "summary": "Healthcare distributor Cencora (NYSE:COR) announced better-than-expected revenue in Q2 CY2025, with sales up 8.7% year on year to $80.66 billion. Its non-GAAP profit of $4 per share was 4.2% above analysts’ consensus estimates.",
      "url": "https://finnhub.io/api/news?id=17008722545f6a64de61fe86e7cdb4fae4f07a77f2b6559214de948579c4a699"
    }
  }
]